Empowering Medicare Advantage Plans to Improve Complex COPD Outcomes

Clinically Validated Disease Management for Complex COPD

77%

of members with Asthma or COPD report zero attacks after 6 months.

65%

of members are still engaged with the program at 1 year

A combination of virtual and asynchronous care pathways to improve health outcomes and reduce avoidable hospital visits.

Respiratory Symptom Reductions Measured Using the Gold-Standard SGRQ Methodology & Validated by Independent Third Party Guarantee

Members experience significantly fewer sleep disturbances due to respiratory symptoms at 6 and 12 months.

Members experience significantly fewer respiratory symptoms during physical activity at 6 and 12 months.

Members experience significantly fewer Asthma attacks and COPD flare-ups at 6 and 12 months, with 77% reporting no attacks.

  • Comprehensive Value-Based COPD Management: Nightingale offers personalized care through virtual and asynchronous pathways, ensuring tailored support for each member.
  • Advanced Monitoring Technology: ADAMM, a proprietary wearable device, tracks respiratory symptoms in real-time, providing insights to caregivers and clinicians.
  • Specialized Respiratory Team: Access to a network of respiratory therapists, pulmonologists, wellness coaches, and behavioral health specialists.
  • Proven Cost Savings & Value-Based: Reduces avoidable hospital visits and lowers overall healthcare costs through effective COPD & asthma management.
  • Turnkey Solution for Plans: Easy integration with Medicare Advantage plans with customizable options and minimal operational burden.

10 years of clinical validation makes the program a market leader